|
1
|
Kitchener HC, Almonte M, Thomson C,
Wheeler P, Sargent A, Stoykova B, Gilham C, Baysson H, Roberts C,
Dowie R, et al: HPV testing in combination with liquid-based
cytology in primary cervical screening (ARTISTIC): A randomised
controlled trial. Lancet Oncol. 10:672–682. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Naucler P, Ryd W, Törnberg S, Strand A,
Wadell G, Elfgren K, Rådberg T, Strander B, Johansson B, Forslund
O, et al: Human papillomavirus and papanicolaou tests to screen for
cervical cancer. N Engl J Med. 357:1589–1597. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Whitlock EP, Vesco KK, Eder M, Lin JS,
Senger CA and Burda BU: Liquid-based cytology and human
papillomavirus testing to screen for cervical cancer: A systematic
review for the U.S. preventive services task force. Ann Intern Med.
155:687–697, W214-W215. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Naucler P, Ryd W, Törnberg S, Strand A,
Wadell G, Elfgren K, Rådberg T, Strander B, Forslund O, Hansson BG,
et al: Efficacy of HPV DNA testing with cytology triage and/or
repeat HPV DNA testing in primary cervical cancer screening. Natl
Cancer Inst. 101:88–99. 2009. View Article : Google Scholar
|
|
5
|
Benoy IH, Vanden Broeck D, Ruymbeke MJ,
Sahebali S, Arbyn M, Bogers JJ, Temmerman M and Depuydt CE: Prior
knowledge of HPV status improves detection of CIN2+ by
cytology screening. Am J Obstet Gynecol. 205:569, e1–e7. 2011.
View Article : Google Scholar
|
|
6
|
Faridi R, Zahra A, Khan K and Idrees M:
Oncogenic potential of human papillomavirus (HPV) and its relation
with cervical cancer. Virol J. 8:2692011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Franceschi S, Denny L, Irwin KL, Jeronimo
J, Lopalco PL, Monsonego J, Peto J, Ronco G, Sasieni P and Wheeler
CM: EUROGIN 2010 roadmap on cervical cancer prevention. Int J
Cancer. 128:2765–2774. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Arbyn M, Sasieni P, Meijer CJ, Clavel C,
Koliopoulos G and Dillner J: Chapter 9: Clinical applications of
HPV testing: A summary of meta-analyses. Vaccine. 24 Suppl
3:S3/78–89. 2006. View Article : Google Scholar
|
|
9
|
de Sanjosé S, Diaz M, Castellsagué X,
Clifford G, Bruni L, Muñoz N and Bosch FX: Worldwide prevalence and
genotype distribution of cervical human papillomavirus DNA in women
with normal cytology: A meta-analysis. Lancet Infect Dis.
7:453–459. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Steenbergen RD, Snijders PJ, Heideman DA
and Meijer CJ: Clinical implications of (epi)genetic changes in
HPV-induced cervical precancerous lesions. Nat Rev Cancer.
14:395–405. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Martinez I, Gardiner AS, Board KF, Monzon
FA, Edwards RP and Khan SA: Human papillomavirus type 16 reduces
the expression of microRNA-218 in cervical carcinoma cells.
Oncogene. 27:2575–2582. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Melar-New M and Laimins LA: Human
papillomaviruses modulate expression of microRNA 203 upon
epithelial differentiation to control levels of p63 proteins. J
Virol. 84:5212–5221. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Greco D, Kivi N, Qian K, Leivonen SK,
Auvinen P and Auvinen E: Human papillomavirus 16 E5 modulates the
expression of host microRNAs. PLoS One. 6:e216462011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zheng ZM and Wang X: Regulation of
cellular miRNA expression by human papillomaviruses. Biochim
Biophys Acta. 1809:668–677. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lajer CB, Garnæs E, Friis-Hansen L,
Norrild B, Therkildsen MH, Glud M, Rossing M, Lajer H, Svane D,
Skotte L, et al: The role of miRNAs in human papilloma virus
(HPV)-associated cancers: Bridging between HPV-related head and
neck cancer and cervical cancer. Br J Cancer. 117:e22017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gómez-Gómez Y, Organista-Nava J and
Gariglio P: Deregulation of the miRNAs expression in cervical
cancer: Human papillomavirus implications. Biomed Res Int.
2013:4070522013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pedroza-Torres A, López-Urrutia E,
Garcia-Castillo V, Jacobo-Herrera N, Herrera LA, Peralta-Zaragoza
O, López-Camarillo C, De Leon DC, Fernández-Retana J, Cerna-Cortés
JF, et al: MicroRNAs in cervical cancer: Evidences for a miRNA
profile deregulated by HPV and its impact on radio-resistance.
Molecules. 19:6263–6281. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang X, Wang HK, Li Y, Hafner M, Banerjee
NS, Tang S, Briskin D, Meyers C, Chow LT, Xie X, et al: microRNAs
are biomarkers of oncogenic human papillomavirus infections. Proc
Natl Acad Sci USA. 111:pp. 4262–4267. 2014; View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gocze K, Gombos K, Kovacs K, Juhasz K,
Gocze P and Kiss I: MicroRNA expressions in HPV-induced cervical
dysplasia and cancer. Anticancer Res. 35:523–530. 2015.PubMed/NCBI
|
|
20
|
He Y, Lin J, Ding Y, Liu G, Luo Y, Huang
M, Xu C, Kim TK, Etheridge A, Lin M, et al: A systematic study on
dysregulated microRNAs in cervical cancer development. Int J
Cancer. 138:1312–1327. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tian Q, Li Y, Wang F, Li Y, Xu J, Shen Y,
Ye F, Wang X, Cheng X, Chen Y, et al: MicroRNA detection in
cervical exfoliated cells as a triage for human
papillomavirus-positive women. J Natl Cancer Inst.
106:pii:dju2412014. View Article : Google Scholar
|
|
22
|
Ribeiro J, Marinho-Dias J, Monteiro P,
Loureiro J, Baldaque I, Medeiros R and Sousa H: miR-34a and
miR-125b expression in HPV infection and cervical cancer
development. Biomed Res Int. 2015:3045842015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pereira PM, Marques JP, Soares AR, Carreto
L and Santos MA: MicroRNA expression variability in human cervical
tissues. PLoS One. 5:e117802010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Galamb Á, Benczik M, Zinner B, Vígh E,
Baghy K, Jeney C, Kiss A, Lendvai G and Sobel G: Dysregulation of
microRNA expression in human cervical preneoplastic and neoplastic
lesions. Pathol Oncol Res. 21:503–508. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ogechukwu OJ: Discordant reports of miRNA
expression in cervical cancer: An upshot of overlapping factors.
Res Cancer Tumor. 4:15–23. 2015.
|
|
26
|
Peltier HJ and Latham GJ: Normalization of
microRNA expression levels in quantitative RT-PCR assays:
Identification of suitable reference RNA targets in normal and
cancerous human solid tissues. RNA. 14:844–852. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mestdagh P, Van Vlierberghe P, De Weer A,
Muth D, Westermann F, Speleman F and Vandesompele J: A novel and
universal method for microRNA RT-qPCR data normalization. Genome
Biology. 10:R642009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pradervand S, Weber J, Thomas J, Bueno M,
Wirapati P, Lefort K, Dotto GP and Harshman K: Impact of
normalization on miRNA microarray expression profiling. RNA.
15:493–501. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kirschner MB, van Zandwijk N and Reid G:
Cell-free microRNAs: Potential biomarkers in need of standardized
reporting. Front Genet. 4:562013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ludwig N, Leidinger P, Becker K, Backes C,
Fehlmann T, Pallasch C, Rheinheimer S, Meder B, Stähler C, Meese E
and Keller A: Distribution of miRNA expression across human
tissues. Nucleic Acids Res. 44:3865–3877. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vandesompele J, De Preter K, Pattyn F,
Poppe B, Van Roy N, De Paepe A and Speleman F: Accurate
normalization of real-time quantitative RT-PCR data by geometric
averaging of multiple internal control genes. Genome Biol.
3:RESEARCH00342002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Solomon D, Davey D, Kurman R, Moriarty A,
O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, et
al: The 2001 Bethesda System: Terminology for reporting results of
cervical cytology. JAMA. 287:2114–2119. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kolesnikov NN, Titov SE, Veryaskina YA,
Vladimirova AV, Samsonov RB, Artem'eva AS, Novik VI, Bershteyn LM,
Zhimulev IF, Malek AV, et al: Improvement of accuracy and
diagnostic significance of breast tumor fine-needle aspiration
biopsy by miRNA analysis of material isolated from cytological
smears. Uspehi Molekulârnoj Onkologii. 3:44–52. 2016. View Article : Google Scholar
|
|
34
|
Titov SE, Demenkov PS, Ivanov MK,
Malakhina ES, Poloz TL, Tsivlikova EV, Ganzha MS, Shevchenko SP,
Gulyaeva LF and Kolesnikov NN: Selection and validation of miRNAs
as normalizers for profiling expression of microRNAs isolated from
thyroid fine needle aspiration smears. Oncology Rep. 36:2501–2510.
2016. View Article : Google Scholar
|
|
35
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jones E, Oliphant E and Peterson P: SciPy:
Open source scientific tools for python. 2001, http://www.scipy.org/July 24–2017 View Article : Google Scholar
|
|
37
|
Pedregosa F, Varoquaux G, Gramfort A,
Michel V, Thirion B, Grisel O, Blondel M, Prettenhofer P, Weiss R,
Dubourg V, et al: Scikit-learn: Machine learning in python. J Mach
Learn Res. 12:2825–2830. 2011.
|
|
38
|
Shen Y, Li Y, Ye F, Wang F, Wan X, Lu W
and Xie X: Identification of miR-23a as a novel microRNA normalizer
for relative quantification in human uterine cervical tissues. Exp
Mol Med. 43:358–366. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Deftereos G, Corrie SR, Feng Q, Morihara
J, Stern J, Hawes SE and Kiviat NB: Expression of mir-21 and
mir-143 in cervical specimens ranging from histologically normal
through to invasive cervical cancer. PLoS One. 6:e284232011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bumrungthai S, Ekalaksananan T, Evans MF,
Chopjitt P, Tangsiriwatthana T, Patarapadungkit N, Kleebkaow P,
Luanratanakorn S, Kongyingyoes B, Worawichawong S and Pientong C:
Up-regulation of miR-21 is associated with cervicitis and human
papillomavirus infection in cervical tissues. PLoS One.
10:e01271092015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Han Y, Xu GX, Lu H, Yu DH, Ren Y, Wang L,
Huang XH, Hou WJ, Wei ZH, Chen YP, et al: Dysregulation of miRNA-21
and their potential as biomarkers for the diagnosis of cervical
cancer. Int J Clin Exp Pathol. 8:7131–7139. 2015.PubMed/NCBI
|
|
42
|
Git A, Dvinge H, Salmon-Divon M, Osborne
M, Kutter C, Hadfield J, Bertone P and Caldas C: Systematic
comparison of microarray profiling, real-time PCR, and
next-generation sequencing technologies for measuring differential
microRNA expression. RNA. 16:991–1006. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jensen SG, Lamy P, Rasmussen MH, Ostenfeld
MS, Dyrskjøt L, Orntoft TF and Andersen CL: Evaluation of two
commercial global miRNA expression profiling platforms for
detection of less abundant miRNAs. BMC Genomics. 12:4352011.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kolbert CP, Feddersen RM, Rakhshan F,
Grill DE, Simon G, Middha S, Jang JS, Simon V, Schultz DA, Zschunke
M, et al: Multi-platform analysis of microRNA expression
measurements in RNA from fresh frozen and FFPE tissues. PLoS One.
8:e525172013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Mestdagh P, Hartmann N, Baeriswyl L,
Andreasen D, Bernard N, Chen C, Cheo D, D'Andrade P, DeMayo M,
Dennis L, et al: Evaluation of quantitative miRNA expression
platforms in the microRNA quality control (miRQC) study. Nat
Methods. 11:809–815. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Farr RJ, Januszewski AS, Joglekar MV,
Liang H, McAulley AK, Hewitt AW, Thomas HE, Loudovaris T, Kay TW,
Jenkins A and Hardikar AA: A comparative analysis of
high-throughput platforms for validation of a circulating microRNA
signature in diabetic retinopathy. Sci Rep. 5:103752015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ben W, Yang Y, Yuan J, Sun J, Huang M,
Zhang D and Zheng J: Human papillomavirus 16 E6 modulates the
expression of host microRNAs in cervical cancer. Taiwan J Obstet
Gynecol. 54:364–370. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Campos-Viguri GE, Jiménez-Wences H,
Peralta-Zaragoza O, Torres-Altamirano G, Soto-Flores DG,
Hernández-Sotelo D, Alarcón-Romero Ldel C, Jiménez-López MA,
Illades-Aguiar B and Fernandez-Tilapa G: miR-23b as a potential
tumor suppressor and its regulation by DNA methylation in cervical
cancer. Infect Agent Cancer. 10:422015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang F, Li Y, Zhou J, Xu J, Peng C, Ye F,
Shen Y, Lu W, Wan X and Xie X: miR-375 is down-regulated in
squamous cervical cancer and inhibits cell migration and invasion
via targeting transcription factor SP1. Am J Pathol. 179:2580–2588.
2011. View Article : Google Scholar : PubMed/NCBI
|
